14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $12.20 $17.80 Wednesday, 1st May 2024 ENTA stock ended at $13.56. This is 1.31% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 5.63% from a day low at $13.51 to a day high of $14.27.
90 days $11.01 $17.80
52 weeks $8.08 $37.14

Historical Enanta Pharmaceuticals prices

Date Open High Low Close Volume
May 03, 2023 $35.16 $35.95 $34.45 $35.49 193 804
May 02, 2023 $37.27 $37.27 $34.93 $35.00 222 095
May 01, 2023 $35.44 $37.75 $35.43 $37.51 183 569
Apr 28, 2023 $34.30 $35.79 $33.35 $35.55 132 272
Apr 27, 2023 $34.56 $35.43 $33.18 $33.97 162 839
Apr 26, 2023 $34.60 $35.14 $34.32 $34.55 167 505
Apr 25, 2023 $36.85 $36.35 $34.65 $34.75 219 780
Apr 24, 2023 $36.92 $37.00 $35.93 $36.37 63 062
Apr 21, 2023 $36.83 $37.25 $36.70 $36.79 86 403
Apr 20, 2023 $37.16 $37.41 $36.40 $36.82 93 011
Apr 19, 2023 $37.17 $37.51 $36.25 $37.26 138 927
Apr 18, 2023 $38.02 $38.30 $36.84 $37.37 113 550
Apr 17, 2023 $36.69 $38.79 $36.67 $38.01 152 344
Apr 14, 2023 $37.28 $38.32 $36.20 $36.53 110 831
Apr 13, 2023 $36.60 $37.89 $36.50 $37.41 147 824
Apr 12, 2023 $38.97 $38.97 $36.42 $36.59 232 837
Apr 11, 2023 $39.15 $39.69 $38.72 $38.76 74 132
Apr 10, 2023 $39.77 $39.77 $38.84 $39.23 107 225
Apr 06, 2023 $38.99 $40.05 $38.71 $39.85 299 406
Apr 05, 2023 $38.72 $39.29 $38.18 $38.49 213 239
Apr 04, 2023 $39.98 $40.24 $38.21 $38.85 191 995
Apr 03, 2023 $40.44 $41.45 $39.64 $39.82 226 224
Mar 31, 2023 $39.49 $40.57 $39.14 $40.44 143 696
Mar 30, 2023 $40.35 $40.55 $38.16 $39.21 139 772
Mar 29, 2023 $39.49 $40.57 $39.11 $40.27 156 730
Click to get the best stock tips daily for free!

About Enanta Pharmaceuticals

Enanta Pharmaceuticals Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A pro... ENTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT